Skip to main content
. Author manuscript; available in PMC: 2019 May 1.
Published in final edited form as: Br J Haematol. 2018 Apr 24;181(4):495–504. doi: 10.1111/bjh.15224

Figure 3.

Figure 3

Hazard ratio for death in aggressive non-Hodgkin lymphomas according to time from diagnosis to start of chemotherapy; non-linear relationship was modelled using a fractional polynomial scaled so that patients with time-to-treatment of 22 days had the reference hazard ratio of 1.0; separate models were fitted for each histology; shaded areas indicate corresponding 95% confidence intervals.